News
News releases on December 10, 2023
Every news release public companies put out on December 10, 2023 (UTC): 16 news releases, newest first. Open any release to read it.
Kingdee International Software: Announces US$200 million Strategic Investment from Qatar Investment Authority
Kingdee International Software Group Co., Ltd. · Dec 10, 2023
Transactions carried out by Sezeka Limited
Richard Pieris & Co PLC · Dec 10, 2023
Retirement of the chief executive officer
National Development Bank PLC · Dec 10, 2023
Proposed amalgamation of Singer Industries (Ceylon) PLC and Regnis (Lanka) PLC with Singer (Sri Lanka) PLC
Singer (Sri Lanka) PLC · Dec 10, 2023
Press Release Dec 10 2023
Shriram Properties Ltd. · Dec 10, 2023
Press Release Dec 10 2023
Tata Motors Passenger Vehicles Ltd · Dec 10, 2023
Press Release Dec 10 2023
Cipla Ltd · Dec 10, 2023
Updated Odronextamab Data from Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep and Durable Responses and the ...
Regeneron Pharmaceuticals, Inc. · Dec 10, 2023
Tsodilo Resources: High Court of Botswana to Render Decision With Respect to Gcwihaba Prospecting Licenses
Tsodilo Resources Limited · Dec 10, 2023
Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting
Schrodinger, Inc. · Dec 10, 2023
Latest Odronextamab Data in Relapsed/Refractory Follicular Lymphoma Showed Compelling Responses and Overall Maintenance of Patient-Report...
Regeneron Pharmaceuticals, Inc. · Dec 10, 2023
Kymera Therapeutics Presents Interim Results from STAT3 Degrader Phase 1 Clinical Trial at American Society of Hematology Annual Meeting
Kymera Therapeutics, Inc. · Dec 10, 2023
Karyopharm Shares Data at ASH 2023 Showing Strong SVR and TSS Durability Observed from Phase 1 Study of Selinexor 60mg and Ruxolitinib in...
Karyopharm Therapeutics Inc. · Dec 10, 2023
Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoieti...
Jasper Therapeutics, Inc. · Dec 10, 2023
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Dura...
Syndax Pharmaceuticals, Inc. · Dec 10, 2023
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Dura...
Incyte Corporation · Dec 10, 2023